Clinical Significance of Monitoring Circulating Free DNA and Plasma Heat Shock Protein 90alpha in Patients with Esophageal Squamous Cell Carcinoma
Authors Zhao Q, Miao C, Lu Q, Wu W, He Y, Wu S, Liu H, Lian C
Received 5 December 2020
Accepted for publication 15 February 2021
Published 5 March 2021 Volume 2021:13 Pages 2223—2234
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Antonella D'Anneo
Qiang Zhao,1 Congxiu Miao,2 Qingpu Lu,1 Weipeng Wu,1 Yuan He,1 Shouxin Wu,3 Huimin Liu,3 Changhong Lian1
1Department of Gastrointestinal Surgery, Heping Hospital, Changzhi Medical College, Changzhi, 046000, Shanxi, People’s Republic of China; 2Department of Science and Technology, Changzhi Medical College, Changzhi, 046000, Shanxi, People’s Republic of China; 3Biotecan Medical Diagnostics Co., Ltd., Zhangjiang Center for Translational Medicine, Shanghai, 201203, People’s Republic of China
Correspondence: Changhong Lian; Huimin Liu Tel +8613835550029
Email [email protected]; [email protected]
Background: Esophageal squamous cell carcinoma (ESCC) is the predominant histological type of esophageal cancer in China and has an extremely poor prognosis. Circulating free DNA (cfDNA) and plasma heat shock protein 90alpha (Hsp90a) are two novel noninvasive biomarkers for diagnosis and prognostic prediction of several types of cancer. However, to the best of our knowledge, the roles of the two biomarkers in ESCC are still unknown.
Methods: Here, we recruited 93 primary ESCC patients and detected plasma concentrations of the two markers at different time points, including 1– 3 days pre-chemotherapy, 1– 7 days pre-surgery and 7– 14 days post-surgery. Baseline concentrations of the two markers were associated with main characteristics of ESCC patients which were collected at first diagnosis. Correlation between the two markers and traditional serum biomarkers at baseline was also examined. Furthermore, dynamic changes of the cfDNA and Hsp90α concentrations among different time points and the potential clinical significance were assessed.
Results: Consequently, there was no significant association between baseline concentrations of the two markers and clinical features. Especially, cfDNA demonstrated stronger correlation with other circulating biomarkers than Hsp90α at baseline level. Importantly, both cfDNA and Hsp90α concentrations were significantly increased after surgery. Kaplan–Meier survival analysis showed that a change in concentration of cfDNA (ΔcfDNA) but not Hsp90α (ΔHSP90ɑ) between pre-surgery and post-surgery had significant effect on the overall survival of surgical patients with ESCC.
Conclusion: Thus, ΔcfDNA evaluation could be a promising prognostic marker for surgical ESCC patients. Our findings may improve the understanding of the function of cfDNA and Hsp90α in ESCC.
Keywords: esophageal squamous cell carcinoma, circulating free DNA, heat shock protein 90alpha, prognostic marker
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]